Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Vrolix

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
American Heart Journal|August 1, 1997
Randomized coronary patency trial of double-bolus recombinant staphylokinase versus front-loaded alteplase in acute myocardial infarctionS Vanderschueren, J Dens, P Kerdsinchai, et al.
European Heart Journal|August 21, 2001
A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction. The PENTALYSE studyP K Coussement, J P Bassand, C Convens, et al.
European Heart Journal|March 13, 1999
A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trialP W Serruys, D P Foley, G Jackson, et al.
Circulation|October 20, 1998
Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) studyM E Bertrand, V Legrand, J Boland, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 1, 2022
The WOEST 2 registry : A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary interventionA J W M de Veer, N Bennaghmouch, W L Bor, et al.
Circulation|March 3, 2004
Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel diseaseVictor M G Legrand, Patrick W Serruys, Felix Unger, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
American Heart Journal|August 1, 1997
Randomized coronary patency trial of double-bolus recombinant staphylokinase versus front-loaded alteplase in acute myocardial infarctionS Vanderschueren, J Dens, P Kerdsinchai, et al.
European Heart Journal|August 21, 2001
A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction. The PENTALYSE studyP K Coussement, J P Bassand, C Convens, et al.
European Heart Journal|March 13, 1999
A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trialP W Serruys, D P Foley, G Jackson, et al.
Circulation|October 20, 1998
Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) studyM E Bertrand, V Legrand, J Boland, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 1, 2022
The WOEST 2 registry : A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary interventionA J W M de Veer, N Bennaghmouch, W L Bor, et al.
Circulation|March 3, 2004
Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel diseaseVictor M G Legrand, Patrick W Serruys, Felix Unger, et al.
Pageof 4